Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway

This study aimed to investigate the effect of sesamol (SEM) on the protein kinase A (PKA) pathway in obesity-related hepatic steatosis treatment by using high-fat diet (HFD)-induced obese mice and a palmitic acid (PA)-treated HepG2 cell line. SEM reduced the body weight gain of obese mice and allevi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hai-Yan, Yu, Liang, Chen, Ji-Hua, Yang, Li-Na, Lin, Cui, Shi, Xiu-Quan, Qin, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071159/
https://www.ncbi.nlm.nih.gov/pubmed/31991934
http://dx.doi.org/10.3390/nu12020329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071159/
https://www.ncbi.nlm.nih.gov/pubmed/31991934
http://dx.doi.org/10.3390/nu12020329

Ejemplares similares